Literature DB >> 6225318

Chemical cholecystitis associated with hepatic artery infusion chemotherapy.

C H Carrasco, P C Freeny, V P Chuang, S Wallace.   

Abstract

The gallbladder often is included within the infusion territory during hepatic arterial chemotherapy, because the cystic artery usually originates from the right hepatic artery. Symptomatic cholecystitis associated with hepatic arterial infusion of mitomycin C and floxuridine or 5-fluorouracil was observed in four instances out of over 700 hepatic arterial infusions of chemotherapeutic agents performed over a 3-year period at two institutions. Arterial infusion chemotherapy is generally well tolerated by the gallbladder, and the true incidence of associated cholecystitis is unknown. Occasionally, angiographic features of cholecystitis are observed in asymptomatic patients after hepatic arterial infusion chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6225318     DOI: 10.2214/ajr.141.4.703

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  8 in total

1.  DSA--control of implanted devices for arterial hepatic perfusion.

Authors:  K Lehner; M Reiser; U Gebhardt; A Heuck; J Schaff
Journal:  Cardiovasc Intervent Radiol       Date:  1987       Impact factor: 2.740

Review 2.  Acalculous disease of the gall bladder.

Authors:  R C Williamson
Journal:  Gut       Date:  1988-06       Impact factor: 23.059

3.  Bile duct strictures associated with hepatic arterial infusion chemotherapy.

Authors:  R A Clark; T E Gallant
Journal:  Gastrointest Radiol       Date:  1987

Review 4.  Clinical significance of and future perspectives for hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer.

Authors:  Sotaro Sadahiro; Toshiyuki Suzuki; Akira Tanaka; Kazutake Okada; Hiroko Kamata; Jun Koisumi
Journal:  Surg Today       Date:  2012-11-10       Impact factor: 2.549

Review 5.  Hepatic artery infusion and chemoembolization in the management of liver metastases.

Authors:  S Wallace; C H Carrasco; C Charnsangavej; W R Richli; K Wright; C Gianturco
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Jun-Jul       Impact factor: 2.740

6.  Emphysematous cholecystitis as a complication of hepatic arterial embolization.

Authors:  D M Coldwell; D W Hottenstein; J A Ricci; P A Wengert
Journal:  Cardiovasc Intervent Radiol       Date:  1985       Impact factor: 2.740

Review 7.  Drug-induced gallbladder disease. Incidence, aetiology and management.

Authors:  P P Michielsen; H Fierens; Y M Van Maercke
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

8.  Effect of caerulein on abdominal pain following transcatheter hepatic arterial embolization in malignant liver cancer patients.

Authors:  K Ido; K Hiramatsu
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.